Cell Therapy Instruments Market, By Product and Cell Types

0

No comments posted yet

Comments

Slide 1

MarketsandMarkets Presents Cell Therapy Instruments Market, By Product and Cell Types https://www.marketsandmarkets.com/Market-Reports/cell-therapy-technologies-market-213334978.html

Slide 2

The report "Cell Therapy Technologies Market by Product (Consumables, Equipment, Software), Cell Type (Human Stem & Differentiated, Animal), Process Stages (Cell Processing, Distribution, Handling, QC), End User, and Region - Global Forecast to 2023" The cell therapy technologies market is projected to reach USD 19.9 billion by 2023 from USD 10.2 billion in 2018, at a CAGR of 14.4%. Factors such as rising government investments for cell-based research, the increasing number of GMP-certified production facilities, and the large number of oncology-oriented cell-based therapy clinical trials are driving the growth of this market. Browse 75 market data Tables and 30 Figures spread through 116 Pages and in-depth TOC on "Cell Therapy Technologies Market by Product (Consumables, Equipment, Software), Cell Type (Human Stem & Differentiated, Animal), Process Stages (Cell Processing, Distribution, Handling, QC), End User, and Region - Global Forecast to 2023" https://www.marketsandmarkets.com/Market-Reports/cell-therapy-technologies-market-213334978.html

Slide 3

Early buyers will receive 10% customization on this report.   https://www.marketsandmarkets.com/Market-Reports/cell-therapy-technologies-market-213334978.html

Slide 4

Consumables segment to account for the largest share of the cell therapy instruments market, by product On the basis of product, the market is segmented into consumables, equipment, and systems & software. The consumables segment is expected to account for the largest share of the cell therapy instruments market in 2018. The large share of this segment is attributed to the high demand for consumables (such as growth factors and media) in cell-based experiments and cancer research and the growing number of new product launches. Moreover, consumables are required at every step of cell processing. This is further expected to drive their adoption in the market. Cell processing segment dominates the cell therapy instruments market in 2018; this trend to continue during the forecast period On the basis of process, the market is segmented into cell processing; cell preservation, distribution, and handling; and process monitoring and quality control. The cell processing segment is expected to account for the largest market share in 2018 and is expected to grow at the highest CAGR during the forecast period. The cell processing stage makes the highest use of cell therapy instruments and media, especially during culture media processing. This is a major factor responsible for the large share and high growth of this segment. https://www.marketsandmarkets.com/Market-Reports/cell-therapy-technologies-market-213334978.html

Slide 5

North America to hold the largest share of the cell therapy instruments market in 2018 The market, by region, is segmented into North America, Europe, Asia Pacific, and the Rest of the World (RoW). North America is expected to account for the largest share of this market in 2018. The large share of this regional segment can primarily be attributed to the high burden of chronic diseases and increasing R&D activities in pharmaceutical and biotechnology industries. The market is dominated by players such as Beckman Coulter, Inc. (US), Becton, Dickinson and Company (US), GE Healthcare (US), Lonza (Switzerland), Merck KGaA (Germany), Miltenyi Biotec (Germany), STEMCELL Technologies, Inc. (Canada), Terumo BCT, Inc. (US), and Thermo Fisher Scientific, Inc. (US). https://www.marketsandmarkets.com/Market-Reports/cell-therapy-technologies-market-213334978.html

Slide 6

https://www.marketsandmarkets.com/Market-Reports/cell-therapy-technologies-market-213334978.html

Slide 7

https://www.marketsandmarkets.com/Market-Reports/cell-therapy-technologies-market-213334978.html

Slide 8

Contact Us Contact: Mr. Shelly Singh MarketsandMarkets™ INC. 630 Dundee Road Suite 430 Northbrook, IL 60062 USA: 1-888-600-6441 Email: sales@marketsandmarkets.com Research Insight: https://www.marketsandmarkets.com/ResearchInsight/cell-therapy-technologies-market.asp Visit Our Website: https://www.marketsandmarkets.com https://www.marketsandmarkets.com/Market-Reports/cell-therapy-technologies-market-213334978.html

Slide 9

About MarketsandMarkets MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world. MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services. They cover thirteen industry verticals, including advanced materials, automotives and transportation, banking and financial services, biotechnology, chemicals, consumer goods, energy and power, food and beverages, industrial automation, medical devices, pharmaceuticals, semiconductor and electronics, and telecommunications and IT. We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository. https://www.marketsandmarkets.com/Market-Reports/cell-therapy-technologies-market-213334978.html

Summary: Get Free Sample Report @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=213334978 The global Cell Therapy Technologies Market is projected to reach USD 19.9 billion by 2023 from USD 10.2 billion in 2018, at a CAGR of 14.4% during the forecast period. Rising government investments for cell-based research, the increasing number of GMP-certified production facilities, and the large number of oncology-oriented cell-based therapy clinical trials are the key factors driving the growth of this market. China, India, Japan, Korea, and Brazil are emerging markets for cell therapy instruments.

Tags: cell therapy instruments market

URL: